Delivery Order SPE2DB20D3505-SPE2DB23FU2E8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,887.51 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a completion date of May 2, 2023. The contract is not designated under any set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FQ2V4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,217.10 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.36 firm fixed-price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,394.49 firm fixed-price delivery order is for the supply of the prescription drug LOW-OGESTREL-28 TABLET 28S. The contract has an ultimate completion date of September 1, 2023. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB23FT41H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,840.19 delivery order contract is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product, with a period of performance through May 9, 2023. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,879.76 firm fixed-price delivery order contract is for the supply of the medication LOW-OGESTREL-28 TABLET 28S. The contract has an ultimate completion date of June 15, 2023 and was awarded on June 14, 2023. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHQ13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,412.97 delivery order contract is for the supply of the pharmaceutical product LOW-OGESTREL-28 TABLET 28S. The contract has a firm-fixed price pricing type and an ultimate completion date of June 6, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a large pharmaceutical distributor. The $1,204.79 firm-fixed price delivery order is for the supply of LOW-OGESTREL-28 TABLET 28S, a contraceptive medication, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company. The contract, valued at $1,483.62, is for the delivery of 4564404760 LOW-OGESTREL-28 TABLET 28S, a prescription medication. The contract does not have a set-aside designation and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major supplier of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,438.01 firm fixed-price delivery order is for "LOW-OGESTREL-28 TABLET 28S", a generic contraceptive medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for the...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU2E8Delivery Order
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FU2E8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,855.60 Firm Fixed Price Delivery Order is for the supply of LOW-OGESTREL-28 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of June 5, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract vehicle. The contract award was made through full and open competition without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 6/2/23 |